A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma.
Objectives: To determine the integrative value of contrast-enhanced computed tomography (CECT), transcriptomics data and clinicopathological data for predicting the survival of bladder urothelial carcinoma (BLCA) patients.Methods: RNA sequencing data, radiomics features and clinical parameters of 62...
| Publicado en: | European Radiology Vol. 30; no. 1; pp. 547 - 558 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | pictorial research tables/charts Journal Article |
| Publicado: |
Springer Nature
Jan2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |